Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Continuous Chemotherapeutic Hyperthermic Peritoneal Perfusion

Known as: CHPP, continuous hyperthermic peritoneal perfusion 
A procedure that bathes the abdominal cavity in fluid that contains anticancer drugs. This fluid is warmer than body temperature. This procedure… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion
There is no standard treatment for peritoneal dissemination from gastric cancer. A novel treatment consisting of peritonectomy… 
Highly Cited
2003
Highly Cited
2003
Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
PURPOSE Liver metastases are the sole or life-limiting component of disease in the majority of patients with ocular melanoma who… 
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2001
Highly Cited
2001
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
BACKGROUND/AIMS Although the most frequent cause of death after curative resection of advanced gastric cancer is peritoneal… 
Highly Cited
1999
Highly Cited
1999
Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
AbstractBackground: Primary peritoneal mesothelioma is a locally aggressive disease that is difficult to treat or even palliate… 
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
1999
Highly Cited
1999
Efficacy of Continuous Hyperthermic Peritoneal Perfusion for the Prophylaxis and Treatment of Peritoneal Metastasis of Advanced Gastric Cancer: Evaluation by Multivariate Regression Analysis
Thirty-two patients with advanced gastric cancer underwent continuous hyperthermic peritoneal perfusion (CHPP) combined with… 
  • table 1
  • table 2
  • figure 1
  • table 4
  • table 3
Highly Cited
1997
Highly Cited
1997
Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
PURPOSE Peritoneal mesothelioma remains a difficult therapeutic challenge. Aggressive debulking combined with continuous… 
Highly Cited
1996
Highly Cited
1996
Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination.
BACKGROUND The most common cause of noncurative resection and recurrence is gastric cancer is peritoneal seeding. However, the… 
Highly Cited
1994
Highly Cited
1994
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study
Background. Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contained 10 μg/ml mitomycin C was devised… 
Highly Cited
1988
Highly Cited
1988
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C
Continuous hyperthermic peritoneal perfusion (CHPP) with a solution that contains mitomycin C (CHPP‐M) has been clinically… 
Highly Cited
1984
Highly Cited
1984
Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug.
To study the feasibility of combined hyperthermic and anticancer drug treatment for peritoneal cancer, we devised a continuous… 
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE